Avisi Technologies, a clinical-stage ophthalmic device company, today announced encouraging six‐month interim results from the VITA trial evaluating its VisiPlate® device, an ultrathin, multichannel ...

Overview of the AI-Based Glaucoma Screening (AI-GS) network. The process begins with an image of the retina captured by a fundus camera. The AI-GS network employs lightweight AI models to analyze ...

Mr. Harrison K. Abutiate, President of GpAG, called for the removal of taxes on glaucoma medications, equipment, and consumables to help patients in advanced stages of the disease. He advised ...